Georgios V Georgakis Selected Research

Georgios V Georgakis Research Topics

Disease

12	Neoplasms (Cancer) 02/2023 - 05/2004
7	Hodgkin Disease (Hodgkin's Disease) 08/2008 - 12/2003
4	Lymphoma (Lymphomas) 10/2005 - 08/2004
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2006 - 12/2003
2	Adenocarcinoma 09/2018 - 03/2006
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2008 - 10/2006
2	Necrosis 03/2006 - 08/2005
1	Colorectal Neoplasms (Colorectal Cancer) 02/2023
1	Stomach Neoplasms (Stomach Cancer) 09/2018
1	Heterotaxy Syndrome 12/2017
1	Pancreatic Fistula (Pancreatic Fistulas) 04/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2008
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2008
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2006
1	Lymphomatoid Papulosis 08/2004
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2004

Drug/Important Bio-Agent (IBA)

4	tanespimycin (17AAG)IBA 12/2006 - 04/2005
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2006 - 04/2005
3	CytokinesIBA 08/2008 - 01/2005
3	Proteins (Proteins, Gene)FDA Link 12/2006 - 05/2004
3	Phosphotransferases (Kinase)IBA 02/2006 - 08/2004
2	Vorinostat FDA Link 08/2008 - 04/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2008 - 01/2006
2	Monoclonal AntibodiesIBA 08/2008 - 08/2005
2	Cyclin D1IBA 04/2008 - 10/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2006 - 08/2005
2	Anaplastic Lymphoma KinaseIBA 12/2006 - 12/2003
2	AntibodiesIBA 01/2006 - 08/2005
2	Death Domain ReceptorsIBA 01/2006 - 08/2005
2	LigandsIBA 01/2006 - 08/2005
2	Bortezomib (Velcade)FDA Link 08/2005 - 05/2004
1	Irinotecan (Camptosar)FDA LinkGeneric 02/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	CD5 AntigensIBA 08/2008
1	Interleukin-6 (Interleukin 6)IBA 08/2008
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2008
1	Interleukin-8 (Interleukin 8)IBA 08/2008
1	Interleukin-10 (Interleukin 10)IBA 08/2008
1	lucatumumabIBA 08/2008
1	TOR Serine-Threonine KinasesIBA 04/2008
1	temsirolimus FDA Link 04/2008
1	B-Cell Activating FactorIBA 02/2007
1	Staphylococcal Protein A (Protein A)IBA 12/2006
1	U 0126 (UO 126)IBA 12/2006
1	Caspase 9IBA 10/2006
1	TNF-Related Apoptosis-Inducing LigandIBA 03/2006
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 03/2006
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2006
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2006
1	Sirolimus (Rapamycin)FDA Link 01/2006
1	Caspase 8 (Caspase-8)IBA 08/2005
1	mapatumumabIBA 08/2005
1	lexatumumabIBA 08/2005
1	geldanamycinIBA 04/2005
1	Imatinib Mesylate (Gleevec)FDA Link 08/2004
1	bcr-abl Fusion ProteinsIBA 08/2004
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 08/2004
1	NF-kappa B (NF-kB)IBA 05/2004
1	NF-KappaB Inhibitor alphaIBA 05/2004
1	Proteasome InhibitorsIBA 05/2004

Therapy/Procedure

6	Therapeutics 09/2018 - 04/2005
2	Investigational Therapies (Experimental Therapy) 10/2005 - 08/2004
1	Hyperthermic Intraperitoneal Chemotherapy 02/2023
1	Surgical Instruments (Clip) 09/2018
1	Precision Medicine 09/2018
1	Operative Surgical Procedures 12/2017
1	Total Parenteral Nutrition 04/2012
1	Length of Stay 04/2012
1	Drug Therapy (Chemotherapy) 01/2006